Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney de Novo Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00229138
What this trial is testing

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 291
Post-approval studies (Phase 4)Ended earlyNCT00522548
What this trial is testing

Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

Who this might be right for
Transplants and Implants
University of Pennsylvania 37
Large-scale testing (Phase 3)Study completedNCT00239863
What this trial is testing

Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 684
Large-scale testing (Phase 3)Study completedNCT00531063
What this trial is testing

This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 237
Post-approval studies (Phase 4)Study completedNCT01266148
What this trial is testing

SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance

Who this might be right for
Renal Function and Chronic Allograft Vasculopathy
Novartis Pharmaceuticals 115
Testing effectiveness (Phase 2)Ended earlyNCT00555789
What this trial is testing

24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 137
Post-approval studies (Phase 4)UnknownNCT03828682
What this trial is testing

Veloxis de Novo Kidney Transplant ECSWD

Who this might be right for
Kidney TransplantationImmunosuppression
Simon Tremblay, PharmD, PhD 60
Large-scale testing (Phase 3)Study completedNCT00140543
What this trial is testing

European Trial of Immunosuppression in SPK Tx

Who this might be right for
Diabetes Mellitus, Type 1Diabetic Nephropathy
EUROSPK Study Group 228
Large-scale testing (Phase 3)Study completedNCT02005562
What this trial is testing

OPERA Study: A Study of Two Dosing Regimens of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche 252
Large-scale testing (Phase 3)Study completedNCT00531440
What this trial is testing

This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 256
Testing effectiveness (Phase 2)Study completedNCT03663335
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 418
Large-scale testing (Phase 3)Study completedNCT00514514
What this trial is testing

Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 802
Post-approval studies (Phase 4)Study completedNCT00195481
What this trial is testing

Study Evaluating Sirolimus in Kidney Transplant Recipients in India

Who this might be right for
Kidney FailureGraft vs Host Disease
Wyeth is now a wholly owned subsidiary of Pfizer 100
Testing effectiveness (Phase 2)Study completedNCT02217410
What this trial is testing

CCFZ533X2201 - PoC Study in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 59
Post-approval studies (Phase 4)UnknownNCT01663805
What this trial is testing

Effects of the Use of "de Novo" Everolimus in Renal Tranplant Population

Who this might be right for
Delayed Function of Renal Transplant
MARIO ABBUD FILHO 80
Post-approval studies (Phase 4)Active Not RecruitingNCT03797196
What this trial is testing

RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients

Who this might be right for
Renal Transplant RecipientsElderly PatientsImmunosuppression
University Medical Center Groningen 374
Large-scale testing (Phase 3)Study completedNCT00251004
What this trial is testing

Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationGraft Rejection
Novartis 833
Not applicableWithdrawnNCT01612299
What this trial is testing

Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients

Who this might be right for
Renal Transplant
University of Kentucky
Post-approval studies (Phase 4)UnknownNCT04700709
What this trial is testing

Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients.

Who this might be right for
Kidney Transplantation
Chong Kun Dang Pharmaceutical 158
Testing effectiveness (Phase 2)Study completedNCT00543569
What this trial is testing

Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 323
Next Page